Original Article
Prognostic factors in advanced pancreatic cancer patients receiving second-line chemotherapy: a single institution experience
Translational Cancer Research
2018;
7
(5)
:1190-1198
.
(31 October 2018)
Serum VEGF during chemo-radiotherapy and its clinical significance in esophageal squamous cell carcinoma
Translational Cancer Research
2018;
7
(5)
:1199-1208
.
(31 October 2018)
Upregulation of exosomal integrin β4 causes osteosarcoma cell proliferation via the PI3K-Akt-mTOR signaling pathway
Translational Cancer Research
2018;
7
(5)
:1209-1220
.
(31 October 2018)
Effect of 17β-estradiol on the migration ability of human osteosarcoma U2OS cells
Translational Cancer Research
2018;
7
(5)
:1221-1227
.
(31 October 2018)
Exploring protocol for breast cancer xenograft model using endothelial colony-forming cells
Translational Cancer Research
2018;
7
(5)
:1228-1234
.
(31 October 2018)
The construction and analysis of gene co-expression network of differentially expressed genes identifies potential biomarkers in thyroid cancer
Translational Cancer Research
2018;
7
(5)
:1235-1243
.
(31 October 2018)
Knockdown of HOTAIR reduces the malignancy of bladder cancer cells via downregulation of invasions and metastasis-related genes
Translational Cancer Research
2018;
7
(5)
:1244-1252
.
(31 October 2018)
Primary malignant melanoma of the esophagus: a population-based study
Translational Cancer Research
2018;
7
(5)
:1253-1262
.
(31 October 2018)
miR-24-3p promotes cell migration and invasion by targeting TEL2 in nasopharyngeal carcinoma
Translational Cancer Research
2018;
7
(5)
:1263-1270
.
(31 October 2018)
Characterization of PD-L1 expression and its prognostic value in patients with ovarian cancer
Translational Cancer Research
2018;
7
(5)
:1271-1281
.
(31 October 2018)
Gut flora shift caused by time-restricted feeding might protect the host from metabolic syndrome, inflammatory bowel disease and colorectal cancer
Translational Cancer Research
2018;
7
(5)
:1282-1289
.
(31 October 2018)
Adherence to Mediterranean diet and the risk of breast cancer: a meta-analysis
Translational Cancer Research
2018;
7
(5)
:1290-1297
.
(31 October 2018)
HRCT features distinguishing minimally invasive adenocarcinomas from invasive adenocarcinomas appearing as mixed ground-glass nodules
Translational Cancer Research
2018;
7
(5)
:1298-1305
.
(31 October 2018)
Editorial
Metformin: a potentially winning therapeutic strategy to prevent breast cancer progression in overweight postmenopausal patients
Translational Cancer Research
2018;
7
(5)
:1306-1309
.
(31 October 2018)
Diminishing marginal cost-effectiveness in risk-targeted lung cancer screening
Translational Cancer Research
2018;
7
(5)
:1310-1312
.
(31 October 2018)
Overdiagnosis in breast cancer screening
Translational Cancer Research
2018;
7
(5)
:1313-1318
.
(31 October 2018)
Molecular imaging biomarkers for breast cancer risk and personalized screening
Translational Cancer Research
2018;
7
(5)
:1319-1325
.
(31 October 2018)
Case Report
Radiation therapy for superficial inguinal lymph node metastases from ovarian clear cell carcinoma and associated inguinal hernia
Translational Cancer Research
2018;
7
(5)
:1326-1330
.
(31 October 2018)
Meet the Professor
Theresa L. Whiteside: if you believe you are correct, stay with it even if no one initially believes you
Translational Cancer Research
2018;
7
(5)
:1331-1333
.
(31 October 2018)
Maria G. Castro: science is a highly collaborative endeavor that transcends different barriers!
Translational Cancer Research
2018;
7
(5)
:1334-1337
.
(31 October 2018)
